RBI
REGN icon

Raiffeisen Bank International’s Regeneron Pharmaceuticals REGN Stock Holding History

Raiffeisen Bank International’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Hold
294
– – ﹤0.01% 522
2026
Q1 		$227K Hold
294
– – ﹤0.01% 481
2025
Q4 		$191K Hold
294
– – ﹤0.01% 470
2025
Q3 		$165K Buy
+294
New +$166K ﹤0.01% 476

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Raiffeisen Bank International's REGN Position: Q2 2026 in Review

Raiffeisen Bank International increased its Regeneron Pharmaceuticals (REGN) stake by 9.6% in Q2 2026, buying an estimated $1.51M and bringing the position to 25,423 shares worth $16.1M. The position accounts for 0.19% of the portfolio, ranked #106.

Raiffeisen Bank International first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.5M in Q4 2025. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Raiffeisen Bank International held 25,423 shares of Regeneron Pharmaceuticals worth $16.1M as of Q2 2026.
  • Raiffeisen Bank International bought 2,220 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.51M.
  • Regeneron Pharmaceuticals made up 0.19% of Raiffeisen Bank International's portfolio in Q2 2026, its #106 holding.
  • Raiffeisen Bank International first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Regeneron Pharmaceuticals position peaked at $17.5M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.